Sectra and Leica Biosystems partner to pursue FDA clearance for an integrated clinical digital pathology solution

Sectra and Leica Biosystems announce collaboration for an integrated clinical pathology solution. The goal is to address the clinical needs of enterprise level customers such as academic medical centers, clinical research organizations and large hospital networks. A 510(k) application for the combined solution has been submitted to the U.S. Food & Drug Administration (FDA).

Please to read the entire article.

You must be logged in to post a comment Login